Related Experiment Videos
dNN study: stavudine, nelfinavir and nevirapine. Preliminary safety, activity and pharmacokinetic interactions
1Brown University School of Medicine, Roger Williams Medical Center, Providence, Rhode Island, USA.
Antiviral Therapy
|March 21, 2000
Abstract:
The dNN study evaluated the safety, efficacy and pharmacokinetic interactions of the combination of stavudine (2',3'-didehydro-2',3'-dideoxythymidine; D4T), nelfinavir and nevirapine in 25 HIV-infected subjects who received treatment for up to 29 weeks. This brief report presents the study design and preliminary data.